@punitbansal14 Nice VCP set up, tight build-up near resistance giving hope for another big rally. My short term target is 920. We can see #ingrevia in 4 digit candidate shortly.
More from Vishnu
🎯Setting up nicely in 10EMA
🎯 Excellent base formation with numerous squats, shakeout and pocket pivots
🎯EPS rate 90, RS rating 80
More detail in thread
@swing_ka_sultan
@Accuracy_Invst @YTA_School @Capt_Kaushaljha @Jitendra_stock @ https://t.co/CRbRYT5feV
#AllCargo
— VCP Charts\U0001f4c8 (@vcpcharts) April 17, 2022
\U0001f3afGood accumulation from base bottom
\U0001f3af Pocket pivots and shakeout will give strength for breakout
\U0001f3af RS strength-81
\U0001f3af EPS strength-90
\U0001f3af Expecting more tightness near pivot point for entry@Accuracy_Invst @swing_ka_sultan @StocksNerd @VVVStockAnalyst @charts_zone pic.twitter.com/yb6pX4Kro5
More from Jubliantingrevia
Any dip till 740 seems a buying opportunity.
Post Q2 it may give decent up move.
#INVESTING https://t.co/gyyuivs0tT
Ideally this should cross four digit in mid term if they maintain similar growth
— JAKERA CHOUDHURY (@Jakerachoudhury) July 22, 2021
Happy that you are making profit in this. Kudos#jubilant ingrevia https://t.co/le7f6bSjuz
Its an extremely informative AR with broad industry & segment wise overview. MUST READ
Lot of moving parts but looks very optimistic & strong growth outlook.
https://t.co/MxuTZDUfFT
https://t.co/ejcXEAQTHH
#JubilantIngrevia Planned Capex of Rs. 900 Cr. in next 3 yrs.
— Mouzam (@mmali09) March 30, 2021
Entry into Diketene derivatives -game changer.
- Import substitution opp. (40% is imported)
- used in Pharma & Agro Chem
- currently at 50% discount to competitor in India
- one of the leading Int. supplier Exit https://t.co/etPtndC1xN pic.twitter.com/WRQUFXHAtR
https://t.co/7YanRjNE8i
#JubilantIngrevia
— Mouzam (@mmali09) June 24, 2021
\U0001f44cAcquisition of 385,100 equity shares worth Rs 21.36 Cr by the promoter group.
Promoter buying is a Big Positive\U0001f3af
Shows that he is confident about its prospects and believes that investing in the company is better than putting money somewhere else.\U0001f4aa\U0001f4c8 https://t.co/vNYcSr3RgV pic.twitter.com/0WnXGN0UYZ
https://t.co/IW0GRBXi7h
#JUBLINGREA
— Mouzam (@mmali09) July 20, 2021
Super Result\U0001f680QoQ/YoY
Despite covid issues
YoY
Rev 1145Cr vs 737cr (+55%)
EBTDA 25% vs 17%
PAT 168cr vs 53cr (+220%)
EPS 10.6 vs 3.3
\U0001f525All 3 engines
\U0001f9eaInteresting Key CAPEX:
- Dietene on schedule
- CDMO GMP - new
- 2 Multipurpose Spl. Chemical plants new https://t.co/vNYcSr3RgV pic.twitter.com/0rcmB1YMfM
https://t.co/GqcV0GbaLD
Bio-Acetaldehyde - Bio based \U0001f9ec, World\u2019s largest manufacturer from \U0001f1ee\U0001f1f3
— Punit (@punitbansal14) July 28, 2021
Image 1: Benefit in carbon footprint as compared to the conventional petroleum route
Image 2: Bio-Acetaldehyde business overview pic.twitter.com/7M2Eqz5maS
You May Also Like
Unfortunately the "This work includes the identification of viral sequences in bat samples, and has resulted in the isolation of three bat SARS-related coronaviruses that are now used as reagents to test therapeutics and vaccines." were BEFORE the
chimeric infectious clone grants were there.https://t.co/DAArwFkz6v is in 2017, Rs4231.
https://t.co/UgXygDjYbW is in 2016, RsSHC014 and RsWIV16.
https://t.co/krO69CsJ94 is in 2013, RsWIV1. notice that this is before the beginning of the project
starting in 2016. Also remember that they told about only 3 isolates/live viruses. RsSHC014 is a live infectious clone that is just as alive as those other "Isolates".
P.D. somehow is able to use funds that he have yet recieved yet, and send results and sequences from late 2019 back in time into 2015,2013 and 2016!
https://t.co/4wC7k1Lh54 Ref 3: Why ALL your pangolin samples were PCR negative? to avoid deep sequencing and accidentally reveal Paguma Larvata and Oryctolagus Cuniculus?